Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Wolfe, Gil I
858  Ergebnisse:
Personensuche X
?
1

Psychometric properties of MG-ADL items and MG-ADL score: A..:

Janssen, Mathieu F. ; Dewilde, Sarah ; Wolfe, Gil I...
Journal of the Neurological Sciences.  463 (2024)  - p. 123135 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Trends and Disparities in the Utilization of Thymectomy for..:

Morganroth, Jennifer ; Zuroff, Leah ; Guidon, Amanda C....
Neurology Clinical Practice.  14 (2024)  5 - p. , 2024
Link: https://doi.org/10.1212/..
 
?
3

Does Surgical Removal of the Thymus Have Deleterious Conseq..:

Kaminski, Henry J. ; Kusner, Linda L. ; Cutter, Gary R....
Neurology.  102 (2024)  12 - p. , 2024
Link: https://doi.org/10.1212/..
 
?
4

Database Evaluation for Muscle and Nerve Diseases - DEMAND:..:

Pasnoor, Mamatha ; Khan, Saud ; Jackson, Carlayne E....
RRNMF Neuromuscular Journal.  4 (2023)  4 - p. , 2023
Link: https://doi.org/10.17161..
 
?
5

Serum metabolomics of treatment response in myasthenia grav..:

Sikorski, Patricia ; Li, Yaoxiang ; Cheema, Mehar...
PLOS ONE.  18 (2023)  10 - p. e0287654 , 2023
Link: https://doi.org/10.1371/..
 
?
6

Phase 2 trial in acetylcholine receptor antibody‐positive m..:

Pasnoor, Mamatha ; Bril, Vera ; Levine, Todd...
European Journal of Neurology.  30 (2023)  5 - p. 1417-1424 , 2023
Link: https://doi.org/10.1111/..
 
?
7

Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibo..:

Nowak, Richard J. ; Coffey, Christopher S. ; Goldstein, Jonathan M....
Neurology.  98 (2022)  4 - p. , 2022
Link: https://doi.org/10.1212/..
 
?
8

Ocular myasthenia gravis – How effective is low dose predni..:

Verma, Rashmi ; Wolfe, Gil I. ; Kupersmith, Mark J.
Journal of the Neurological Sciences.  420 (2021)  - p. 117274 , 2021
Link: https://doi.org/10.1016/..
 
?
9

Contributors:

, In: Neurotherapeutics in the Era of Translational Medicine,
Aboody, Karen ; Aladesuyi Arogundade, Olubankole ; Appendino, Giovanni... - p. xi-xiv , 2021
Link: https://doi.org/10.1016/..
 
?
10

IgG regulation through FcRn blocking: A novel mechanism for..:

Wolfe, Gil I. ; Ward, E. Sally ; de Haard, Hans...
Journal of the Neurological Sciences.  430 (2021)  - p. 118074 , 2021
Link: https://doi.org/10.1016/..
 
?
11

Post-intervention Status in Patients With Refractory Myasth..:

Mantegazza, Renato ; Wolfe, Gil I. ; Muppidi, Srikanth...
Neurology.  96 (2021)  4 - p. , 2021
Link: https://doi.org/10.1212/..
 
?
12

Advances in treating myasthenia gravis:

, In: Neurotherapeutics in the Era of Translational Medicine,
Lee, Ikjae ; Wolfe, Gil I. - p. 243-264 , 2021
Link: https://doi.org/10.1016/..
 
?
13

Immunoglobulin administration for the treatment of CIDP: IV..:

Allen, Jeffrey A. ; Gelinas, Deborah F. ; Freimer, Miriam..
Journal of the Neurological Sciences.  408 (2020)  - p. 116497 , 2020
Link: https://doi.org/10.1016/..
 
?
14

Is the treatment of myasthenia gravis improving?: Why not a..:

Piehl, Fredrik ; Wolfe, Gil I.
Neurology.  95 (2020)  12 - p. 509-510 , 2020
Link: https://doi.org/10.1212/..
 
?
15

Correlation of Quantitative Myasthenia Gravis and Myastheni..:

McPherson, Tarrant ; Aban, Inmaculada ; Duda, Petra W....
Muscle & Nerve.  62 (2020)  2 - p. 261-266 , 2020
Link: https://doi.org/10.1002/..
 
1-15